The Centers for Disease Control and Prevention announced Thursday that it will begin testing the use of some of the medications used to treat vertigo in Colorado and Indiana.
The testing is part of a nationwide effort to find new treatments for the condition, which has declined dramatically in recent years.
The CDC also said it will be testing other drugs, including antihistamines, that can slow the symptoms of vertigo.
The tests are part of efforts to develop new medications that work better in patients with more severe symptoms, and also to test a treatment that is already available for people with a history of serious diseases.
It is not yet known if the medications will be approved for use in people with serious conditions.
The agency has tested some of these medications before, but the agency said there are many drugs that have not been tested for potential side effects.
The Centers have been working on a pilot project for a few years to test some of them.
The drugs are known as “vertigo medications,” because they are believed to treat symptoms caused by the eye movement disorder that affects about 2 percent of people.
Some of the drugs are prescribed for people who have a history or who have other medical conditions.
They can help people who can’t tolerate the medication or to treat some of its side effects, such as fatigue, sleep disturbances and dizziness.
The medications were developed to treat a condition that affects the eyes and scalp, as well as the eyes, throat and other parts of the body.
Some have also been used to help treat severe dizziness, nausea and other problems associated with the condition.
Some people with severe vertigo often have other health conditions that are often more severe.
One such condition is neurodegenerative diseases, which can lead to death.
They include Alzheimer’s disease, Parkinson’s disease and other dementias.
Vertigo medications are typically used to control the symptoms caused or worsen by other conditions that affect the eyes or the brain.
The FDA said Thursday it will start testing drugs that work against the eye disease.
The move comes as some states and communities in the country are testing drugs to treat the condition that is declining in the United States, including Colorado and Virginia.
The U.S. Department of Health and Human Services (HHS) said in April it had approved a drug called Tisarix, which works against the disease in people who are already taking it, and will soon begin a study on the use in adults.
The drug is also being tested in people whose eyesight has been affected by glaucoma, and is being studied for its ability to slow the progression of eye disease and reduce the severity of the condition in people.